觀點金融監管

Time to rebuild the twin pillars of 1930s Wall Street

Last Thursday was Groundhog Day, again, in US markets. A large sophisticated institution surprised everyone with a 10-figure loss on derivatives, its stock price crumbled, a few pundits said “I told you so”, and some politicians clamoured for reform. The same happened in 1995 with Barings Bank, in 1998 with Long-Term Capital Management, in 2000 with Enron, and in 2008 with several Wall Street businesses, notably Lehman Brothers and AIG. Four days ago it happened with JPMorgan Chase, which stunned investors with a $2bn derivatives loss.

In each case the victim was thought to be a well-run, relatively safe institution. And in each case the culprit was financial innovation and mathematical models that wrongly suggested positions were low-risk. Each of these firms traded complex financial contracts and then used a single number – “value at risk” – to estimate its maximum probable loss, just as a weather forecaster might estimate the likely cost of hurricanes during an upcoming season.

Until recently, JPMorgan put its value at risk for the relevant trades at just $67m, meaning it had calculated that 95 per cent of the time it would not lose any more than this amount. Given that disclosure, investors might have imagined a worst-case scenario loss of $100m – but not $2bn. Ominously, Jamie Dimon, the bank’s chief executive, warned on Thursday that losses might escalate even higher and admitted that the model the bank used to calculate its trading risks was “inadequate.” Twenty-four hours later, $14bn had been wiped off JPMorgan’s market capitalisation.

您已閱讀33%(1568字),剩餘67%(3254字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。

中東期待沙烏地阿拉伯制衡川普

阿拉伯國家希望穆罕默德王儲和美國當選總統川普的密切關係能夠緩和川普政府的中東政策。

投資者押注防務支出增加,Palantir成爲「川普交易」贏家之一

彼得•蒂爾創立的數據公司的最大客戶是美國政府,自川普本月當選以來,其市值增加了230億美元。

Lex專欄:成長來之不易,雀巢前景平淡

要實現其成長目標,這家瑞士集團需要增加行銷投資。

Lex專欄:便宜商品是沃爾瑪股價上漲的基礎

沃爾瑪通過吸引高收入顧客和增加其他收入來源,出色地應對了經濟不景氣和通膨帶來的挑戰。

Lex專欄:奢侈品品牌寄希望於自己的美國夢

奢侈品在美國越來越具有吸引力,可能爲該行業提供新的成長跑道。

諾和諾德準備下一代減肥藥的試驗結果

這家丹麥公司預計,最新數據將顯示CagriSema可在一年多的時間內減輕25%的體重。
設置字型大小×
最小
較小
默認
較大
最大
分享×